| Product Code: ETC6144732 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Personalized Cancer Vaccines Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Personalized Cancer Vaccines Market - Industry Life Cycle |
3.4 Argentina Personalized Cancer Vaccines Market - Porter's Five Forces |
3.5 Argentina Personalized Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Argentina Personalized Cancer Vaccines Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.7 Argentina Personalized Cancer Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Argentina Personalized Cancer Vaccines Market Revenues & Volume Share, By Bio-Maker Type, 2021 & 2031F |
3.9 Argentina Personalized Cancer Vaccines Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.10 Argentina Personalized Cancer Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Argentina Personalized Cancer Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Argentina Personalized Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer in Argentina |
4.2.2 Increasing investments in personalized medicine and immunotherapy |
4.2.3 Technological advancements in cancer vaccine development |
4.3 Market Restraints |
4.3.1 High costs associated with personalized cancer vaccines |
4.3.2 Regulatory challenges and approval processes |
4.3.3 Lack of awareness and education about personalized cancer vaccines |
5 Argentina Personalized Cancer Vaccines Market Trends |
6 Argentina Personalized Cancer Vaccines Market, By Types |
6.1 Argentina Personalized Cancer Vaccines Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.4 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.5 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Leukaemia, 2021- 2031F |
6.1.7 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.8 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2 Argentina Personalized Cancer Vaccines Market, By Mechanism of Action Type |
6.2.1 Overview and Analysis |
6.2.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-associated Antigens (TAAs), 2021- 2031F |
6.2.3 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-specific Antigens (TSAs), 2021- 2031F |
6.2.4 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Somatic Mutations in Cancer Pharmacogenomics, 2021- 2031F |
6.2.5 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics towards Genomic Polymorphism, 2021- 2031F |
6.3 Argentina Personalized Cancer Vaccines Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Dendritic Cells (DC) Cancer Vaccines, 2021- 2031F |
6.3.3 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Recombinant Cancer Vaccines, 2021- 2031F |
6.3.4 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Antigen/Adjuvant Cancer Vaccines, 2021- 2031F |
6.3.5 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Viral Vector and DNA Cancer Vaccines, 2021- 2031F |
6.4 Argentina Personalized Cancer Vaccines Market, By Bio-Maker Type |
6.4.1 Overview and Analysis |
6.4.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.4.3 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Prognostic and Predictive Biomarkers, 2021- 2031F |
6.4.4 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Immune Checkpoint Biomarkers, 2021- 2031F |
6.4.5 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Argentina Personalized Cancer Vaccines Market, By Treatment Type |
6.5.1 Overview and Analysis |
6.5.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Preventive Cancer Vaccines, 2021- 2031F |
6.5.3 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Therapeutic Cancer Vaccines, 2021- 2031F |
6.6 Argentina Personalized Cancer Vaccines Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Injectables, 2021- 2031F |
6.6.3 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Argentina Personalized Cancer Vaccines Market, By End Users |
6.7.1 Overview and Analysis |
6.7.2 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Argentina Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Argentina Personalized Cancer Vaccines Market Import-Export Trade Statistics |
7.1 Argentina Personalized Cancer Vaccines Market Export to Major Countries |
7.2 Argentina Personalized Cancer Vaccines Market Imports from Major Countries |
8 Argentina Personalized Cancer Vaccines Market Key Performance Indicators |
8.1 Patient response rates to personalized cancer vaccines |
8.2 Number of clinical trials and research studies conducted |
8.3 Adoption rates of personalized cancer vaccines in Argentina |
8.4 Percentage of healthcare professionals trained in administering personalized cancer vaccines |
8.5 Funding and investments in personalized cancer vaccine research and development |
9 Argentina Personalized Cancer Vaccines Market - Opportunity Assessment |
9.1 Argentina Personalized Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Argentina Personalized Cancer Vaccines Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
9.3 Argentina Personalized Cancer Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Argentina Personalized Cancer Vaccines Market Opportunity Assessment, By Bio-Maker Type, 2021 & 2031F |
9.5 Argentina Personalized Cancer Vaccines Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.6 Argentina Personalized Cancer Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Argentina Personalized Cancer Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Argentina Personalized Cancer Vaccines Market - Competitive Landscape |
10.1 Argentina Personalized Cancer Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Argentina Personalized Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here